ACTUATE THERAPEUTICS, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Operating income | -$22.5M | -$25.2M | -$25.0M |
| Operating expenses | $22.5M | $25.2M | $25.0M |
| Cash from operations | -$19.2M | -$21.8M | -$21.6M |
| Total assets | $14.0M | $9.3M | $3.0M |
| Total liabilities | $6.1M | $9.2M | $8.4M |
Shares outstanding 23.9M · Free float 40.3%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.